{{Rsnum
|rsid=4444073
|Chromosome=11
|position=10310117
|Orientation=plus
|GMAF=0.343
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;C)
|geno3=(C;C)
|Gene=CAND1.11
|Gene_s=CAND1.11
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;C)
| geno3=(C;C)
| CEU | 24.8 | 54.9 | 20.4
| HCB | 55.5 | 38.0 | 6.6
| JPT | 51.3 | 37.2 | 11.5
| YRI | 68.7 | 28.6 | 2.7
| ASW | 71.9 | 22.8 | 5.3
| CHB | 55.5 | 38.0 | 6.6
| CHD | 55.0 | 34.9 | 10.1
| GIH | 43.0 | 46.0 | 11.0
| LWK | 63.6 | 30.0 | 6.4
| MEX | 44.8 | 44.8 | 10.3
| MKK | 53.2 | 36.5 | 10.3
| TSI | 40.2 | 43.1 | 16.7
| HapMapRevision=28
}}{{PMID Auto
|PMID=24147025
|Title=Sex-Specific Effects of NLRP6/AVR and ADM Loci on Susceptibility to Essential Hypertension in a Sardinian Population
|OA=1
}}

{{PMID Auto
|PMID=17903303
|Title=Genome-wide association study for subclinical atherosclerosis in major arterial territories in the NHLBI's Framingham Heart Study.
|OA=1
}}

{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Illumina Human 1M}}